RCUS logo

Arcus Biosciences (RCUS) EBIT

Annual EBIT

-$279.00 M
+$20.00 M+6.69%

December 31, 2024

Summary

Performance

1-Year Change

+6.69%

3-Year Change

-607.27%

5-Year Change

-229.36%

15-Year Change

-422.07%

RCUS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.58%
RCUS annual earnings before interest & taxes is higher than 5.58% of companies in Healthcare sector

High & Low

All-time High

$55.00 M
RCUS annual earnings before interest & taxes is currently -607.27% below its historical high of $55.00 million

3-Year Low

-$299.00 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RCUS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RCUS next annual earnings announcement has not yet been scheduled

OtherRCUSprofitabilitymetrics:

Annual Revenue

$258.00 M
RCUS annual revenue is $258.00 million

Annual Net Income

-$283.00 M
RCUS annual net profit is -$283.00 million

Annual EBITDA

-$269.00 M
RCUS annual EBITDA is -$269.00 million

Annual EPS

-$3.14
RCUS annual earnings per share is -$3.14

Quarterly EBIT

-$92.00 M
-$1.00 M-1.10%

December 31, 2024

Summary

Performance

3-Month Change

-1.1%

1-Year Change

-15%

3-Year Change

-132.68%

5-Year Change

-580.07%

RCUS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.94%
RCUS quarterly earnings before interest & taxes is higher than 4.94% of companies in Healthcare sector

High & Low

All-time High

$281.54 M
RCUS quarterly earnings before interest & taxes is currently -132.68% below its historical high of $281.54 million

3-Year Low

-$93.00 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUSprofitabilitymetrics:

Quarterly Revenue

$26.00 M
RCUS quarterly revenue is $26.00 million

Quarterly Net Income

-$94.00 M
RCUS quarterly net profit is -$94.00 million

Quarterly EBITDA

-$89.00 M
RCUS quarterly EBITDA is -$89.00 million

Quarterly EPS

-$1.03
RCUS quarterly earnings per share is -$1.03

TTM EBIT

-$279.00 M
-$12.00 M-4.49%

December 31, 2024

Summary

Performance

3-Month Change

-4.49%

1-Year Change

+6.69%

3-Year Change

-607.27%

5-Year Change

-229.36%

RCUS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.8%
RCUS TTM earnings before interest & taxes is higher than 5.8% of companies in Healthcare sector

High & Low

All-time High

$83.54 M
RCUS TTM earnings before interest & taxes is currently -433.98% below its historical high of $83.54 million

3-Year Low

-$299.00 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUSprofitabilitymetrics:

TTM Revenue

$258.00 M
RCUS TTM revenue is $258.00 million

TTM Net Income

-$283.00 M
RCUS TTM net profit is -$283.00 million

TTM EBITDA

-$269.00 M
RCUS TTM EBITDA is -$269.00 million

TTM EPS

-$3.10
RCUS TTM earnings per share is -$3.10

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$279.00 M
RCUS annual earnings before interest & taxes is -$279.00 million

Annual Revenue

$258.00 M
RCUS annual revenue is $258.00 million

Annual Cost Of Goods Sold

-
RCUS annual cost of goods sold value is unknown

Annual Operating Expenses

$568.00 M
RCUS annual total operating expenses is $568.00 million

RCUS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.7%-15.0%+6.7%
3 y3 years-607.3%-132.7%-607.3%
5 y5 years-229.4%-580.1%-229.4%

RCUS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-607.3%+6.7%-132.7%+1.1%-434.0%+6.7%
5 y5-year-607.3%+6.7%-132.7%+1.1%-434.0%+6.7%
alltimeall time-607.3%+6.7%-132.7%+1.1%-434.0%+6.7%

Arcus Biosciences EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-$279.00 M(-6.7%)
-$92.00 M(+1.1%)
-$279.00 M(+4.5%)
Sep 2024
-
-$91.00 M(-2.2%)
-$267.00 M(+9.4%)
Jun 2024
-
-$93.00 M(+3000.0%)
-$244.00 M(+8.4%)
Mar 2024
-
-$3.00 M(-96.3%)
-$225.00 M(-24.7%)
Dec 2023
-$299.00 M(+13.3%)
-$80.00 M(+17.6%)
-$299.00 M(+4.9%)
Sep 2023
-
-$68.00 M(-8.1%)
-$285.00 M(+1.1%)
Jun 2023
-
-$74.00 M(-3.9%)
-$282.00 M(+2.9%)
Mar 2023
-
-$77.00 M(+16.7%)
-$274.00 M(+3.8%)
Dec 2022
-$264.00 M(-580.0%)
-$66.00 M(+1.5%)
-$264.00 M(-416.0%)
Sep 2022
-
-$65.00 M(-1.5%)
$83.54 M(+18.4%)
Jun 2022
-
-$66.00 M(-1.5%)
$70.56 M(+16.5%)
Mar 2022
-
-$67.00 M(-123.8%)
$60.59 M(+10.2%)
Dec 2021
$55.00 M(-144.7%)
$281.54 M(-461.1%)
$55.00 M(-119.8%)
Sep 2021
-
-$77.97 M(+2.6%)
-$277.31 M(+40.2%)
Jun 2021
-
-$75.97 M(+4.7%)
-$197.79 M(+18.3%)
Mar 2021
-
-$72.59 M(+43.0%)
-$167.19 M(+35.9%)
DateAnnualQuarterlyTTM
Dec 2020
-$123.00 M(+45.2%)
-$50.78 M(-3371.7%)
-$123.00 M(+43.4%)
Sep 2020
-
$1.55 M(-103.4%)
-$85.75 M(-22.4%)
Jun 2020
-
-$45.38 M(+59.8%)
-$110.55 M(+17.2%)
Mar 2020
-
-$28.40 M(+109.9%)
-$94.34 M(+11.4%)
Dec 2019
-$84.71 M(+54.4%)
-$13.53 M(-41.8%)
-$84.71 M(+0.1%)
Sep 2019
-
-$23.25 M(-20.3%)
-$84.67 M(+15.1%)
Jun 2019
-
-$29.16 M(+55.3%)
-$73.56 M(+22.0%)
Mar 2019
-
-$18.77 M(+39.2%)
-$60.30 M(+9.9%)
Dec 2018
-$54.86 M(+2.7%)
-$13.48 M(+11.0%)
-$54.86 M(+0.3%)
Sep 2018
-
-$12.14 M(-23.6%)
-$54.72 M(-16.7%)
Jun 2018
-
-$15.90 M(+19.3%)
-$65.71 M(+10.5%)
Mar 2018
-
-$13.33 M(-0.1%)
-$59.47 M(+11.3%)
Dec 2017
-$53.44 M(+193.9%)
-$13.34 M(-42.3%)
-$53.44 M(+33.3%)
Sep 2017
-
-$23.13 M(+139.4%)
-$40.10 M(+136.4%)
Jun 2017
-
-$9.66 M(+32.4%)
-$16.96 M(+132.4%)
Mar 2017
-
-$7.30 M
-$7.30 M
Dec 2016
-$18.18 M
-
-

FAQ

  • What is Arcus Biosciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Arcus Biosciences?
  • What is Arcus Biosciences annual EBIT year-on-year change?
  • What is Arcus Biosciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Arcus Biosciences?
  • What is Arcus Biosciences quarterly EBIT year-on-year change?
  • What is Arcus Biosciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Arcus Biosciences?
  • What is Arcus Biosciences TTM EBIT year-on-year change?

What is Arcus Biosciences annual earnings before interest & taxes?

The current annual EBIT of RCUS is -$279.00 M

What is the all time high annual EBIT for Arcus Biosciences?

Arcus Biosciences all-time high annual earnings before interest & taxes is $55.00 M

What is Arcus Biosciences annual EBIT year-on-year change?

Over the past year, RCUS annual earnings before interest & taxes has changed by +$20.00 M (+6.69%)

What is Arcus Biosciences quarterly earnings before interest & taxes?

The current quarterly EBIT of RCUS is -$92.00 M

What is the all time high quarterly EBIT for Arcus Biosciences?

Arcus Biosciences all-time high quarterly earnings before interest & taxes is $281.54 M

What is Arcus Biosciences quarterly EBIT year-on-year change?

Over the past year, RCUS quarterly earnings before interest & taxes has changed by -$12.00 M (-15.00%)

What is Arcus Biosciences TTM earnings before interest & taxes?

The current TTM EBIT of RCUS is -$279.00 M

What is the all time high TTM EBIT for Arcus Biosciences?

Arcus Biosciences all-time high TTM earnings before interest & taxes is $83.54 M

What is Arcus Biosciences TTM EBIT year-on-year change?

Over the past year, RCUS TTM earnings before interest & taxes has changed by +$20.00 M (+6.69%)